RETRACTED ARTICLE:Interactions between Th1 cells and Tregsaffect regulation of hepatic fibrosis in biliary atresia through the IFN-γ/STAT1 pathway

Jie Wen, Minghao Yin, Jun Wang, Jie Chen, Wenbo Yan, Jin Wu, Junkai Yan, Kejun Zhou, Yongtao Xiao, Yang Wang, Qiang Xia, Wei CaiCell 2017 · DOI · OpenAlex

Abstract

Biliary atresia (BA) is a severe pediatric liver disease characterized by progressive bile duct destruction and rapid liver fibrosis. This study investigated the roles of regulatory T cells (Tregs) and Th1 cells in driving this fibrotic process. Analyzing 146 BA patients, researchers identified a significant deficiency in suppressive Tregs alongside an expansion of pro-inflammatory Th1, Th2, and Th17 subsets. Notably, intrahepatic Th1 cell frequency positively correlated with the severity of liver fibrosis. Mechanistically, Th1 cells were found in close proximity to activated hepatic stellate cells (HSCs) and promoted their profibrogenic activity via the IFN-γ/STAT1 pathway. Tregs were shown to mitigate this effect by inhibiting STAT1 activation. These findings suggest that the Th1/Treg imbalance is a key driver of progressive liver scarring in BA.

Introduction

Biliary atresia (BA) remains a leading cause of pediatric liver transplantation. Despite surgical intervention (Kasai portoenterostomy), many infants progress to end-stage liver disease due to unrelenting hepatic fibrosis. While immune-mediated bile duct injury is well-documented, the specific immune mechanisms fueling the subsequent fibrotic process have been less clear. This research explores the interplay between pro-inflammatory Th1 cells and suppressive Tregs in the activation of hepatic stellate cells (HSCs), the primary effectors of liver scarring.

Methodology

The study enrolled 146 BA patients (128 early-stage, 18 late-stage) and 20 healthy controls between 2013 and 2016. Researchers utilized flow cytometry to characterize T-cell subsets in peripheral blood, lymph nodes, and liver biopsies. Immunofluorescence and immunohistochemistry were employed to map the spatial distribution of these cells relative to fibrotic markers. Functional assays involved co-culturing patient-derived Th1 cells and Tregs with primary human HSCs, using siRNA knockdown and neutralizing antibodies to dissect the underlying signaling pathways.

Key Findings

1. Systemic and Intrahepatic Immune Imbalance

BA patients exhibited a marked decrease in the frequency of CD4+CD25+Foxp3+ Tregs compared to healthy controls. Conversely, there was a significant increase in pro-inflammatory Th1 (IFN-γ+), Th2 (IL-4+), and Th17 (IL-17+) cell populations. Interestingly, the percentage of Tregs showed a modest recovery in patients following liver transplantation (LT), suggesting the diseased liver environment contributes to the immune imbalance.

Figure 1: Flow cytometry analysis showing the proportions of Tregs and Th1/Th2/Th17 cells in BA patients compared to controls, along with correlations between Th subsets and liver fibrosis stage.

2. Th1 Cells Drive Hepatic Stellate Cell Activation

The study found a strong positive correlation between the frequency of intrahepatic Th1 cells and the histological stage of liver fibrosis. Spatial analysis revealed that T-bet+ Th1 cells were localized in close proximity to α-SMA+ activated HSCs within fibrotic regions of BA livers, suggesting direct cellular cross-talk.

Figure 2: Immunofluorescence staining showing the close proximity of T-bet+ Th1 cells (green) to α-SMA+ activated hepatic stellate cells (red) in BA liver tissue across fibrosis stages I-IV.

In vitro experiments demonstrated that Th1 cells accelerate HSC proliferation and increase the expression of profibrogenic markers, including MMP2, TIMP1, and Collagen I. This activation was mediated by Th1-secreted IFN-γ, which triggers the STAT1 signaling pathway in HSCs.

3. Regulatory Role of Tregs

Tregs were found to act as a critical counter-regulatory mechanism. In co-culture systems, the addition of Tregs effectively suppressed Th1-induced HSC activation. This suppression was achieved by inhibiting the phosphorylation (activation) of STAT1 in the stellate cells. Furthermore, Th1 cells were observed to upregulate a subset of activated Tregs (aTregs) via IFN-γ, suggesting a complex feedback loop aimed at maintaining immune homeostasis.

Conclusion and Note on Retraction

The study concludes that an aberrant Th1 immune response, coupled with a Treg deficiency, promotes progressive liver fibrosis in BA through the IFN-γ/STAT1 axis. Modulating the Th1/Treg balance is proposed as a potential therapeutic strategy to slow disease progression.

Important Note: This article has been retracted by the journal. Readers should exercise caution as the reliability of the presented data and conclusions has been called into question by the editorial board.

Summary updated

Abstract

Regulatory T cells (Tregs) and CD4<sup>+</sup> T helper (Th) cells have important roles in bile duct injury of biliary atresia (BA). However, their impacts on liver fibrosis are undefined. Between 2013 and 2016, 146 patients with various stages of BA were enrolled in this study. Peripheral blood, liver biopsy and lymph node samples were collected. Flow cytometry, magnetic cell sorting and immunostaining were used to characterize lymphocytes from BA patients. Deficiency of Tregs was observed along with increased Th1, Th2 and Th17 frequencies in the peripheral blood and livers of BA patients. The levels of peripheral and intrahepatic Th1 cells positively correlated with the stage of liver fibrosis. Furthermore, Th1 cells were located in close proximity to activated hepatic stellate cells (HSCs) and areas of fibrosis in BA livers. In culture, Th1 cells accelerated the proliferation and secretion of profibrogenic markers of HSCs through the IFN-γ/STAT1 pathway. Of note, Tregs blocked the Th1-stimulated effects on HSCs by inhibiting Th1-induced activation of STAT1. Consistent with the results of in vitro study, intrahepatic IFN-γ/STAT1 levels increased in relation to the severity of liver fibrosis in BA patients, and the altered balance between MMP2 and TIMP1 expressions in livers may contribute to increased deposition of extracellular matrix and fibrosis. Finally, to identify the effects of Th1 cells on Tregs, we demonstrated that Th1 cells upregulated the proportion of aTreg cells by secreting IFN-γ cytokine. Thus, aberrant Th1 immune responses in BA promote the proliferation and secretion of HSCs through the IFN-γ/STAT1 pathway. The regulation of HSCs by the interactions between Tregs and Th1 cells might be part of the mechanism underlying progressive liver fibrosis and may be a suitable target for therapy.
BibTeX
@inproceedings{wen2017retracted,
  author = {Jie Wen and Minghao Yin and Jun Wang and Jie Chen and Wenbo Yan and Jin Wu and Junkai Yan and Kejun Zhou and Yongtao Xiao and Yang Wang and Qiang Xia and Wei Cai},
  title = {{RETRACTED ARTICLE:Interactions between Th1 cells and Tregsaffect regulation of hepatic fibrosis in biliary atresia through the IFN-γ/STAT1 pathway}},
  booktitle = {Cell},
  year = {2017},
  doi = {10.1038/cdd.2017.31},
}
Figure